|
|
 |
||||||||||||||||||
|
|
Dear Colleague, It gives me pleasure to invite you to participate in the Biotech Israel 2004 - 3rd National Biotechnology Conference and Exhibition. Notwithstanding the obvious difficulties, the Israeli biotechnology community is witness to a steady progress, and this demands a forum where scientists in the various biotechnology areas can meet with entrepreneurs, physicians, legal and patent advisors, as well as regulators and corporate executives. The constructive dialogue is needed more than ever, resulting, hopefully, in a dynamic flow and exchange among conference participants. The conference will include four plenary lectures,three by visiting scientists and business leaders and one by a leading Israeli industrialist. It will include sessions on gene diseases, devices in medicine, stem cells and therapy, gene therapy, immunotherapy, neurobiology, nanobiotech, bioinformatics, agricultural biotech, and structural biology. It will also include a special session on future challenges in biotechnology and a round table on the tortuous progress in biotech. The business track will provide an overview of the state of the global biotech industry, with specific emphasis on key pharma and biotech trends. It will also focus on the challenges and opportunities facing the Israeli industry, and propose a framework for value generation. The conference will also provide the audience with an opportunity to interact with some of Israel's most promising biotech companies. Thus, the entire biotech community has joined this national reunion, hopefully leading to a dialogue and a new vision. Prof. Michael Sela |
||||||||||||||||
|
|
|
